Sterneck Capital Management’s Gilead Sciences GILD Stock Holding History

Sterneck Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,544	Closed	-$281K	–	94
2022 Q2	$281K	Buy	4,544 +750	+20%	+$46.4K	0.19%	71
2022 Q1	$226K	Sell	3,794 -274	-7%	-$17.5K	0.14%	84
2021 Q4	$295K	Hold	4,068	–	–	0.17%	78
2021 Q3	$284K	Hold	4,068	–	–	0.18%	75
2021 Q2	$285K	Buy	+4,068	New	+$272K	0.18%	72
2020 Q2	–	Sell	-2,931	Closed	-$219K	–	77
2020 Q1	$219K	Sell	2,931 -32,686	-92%	-$2.26M	0.22%	70
2019 Q4	$2.31M	Buy	35,617 +862	+2%	+$56.1K	1.84%	13
2019 Q3	$2.2M	Sell	34,755 -934	-3%	-$61.1K	2.01%	13
2019 Q2	$2.41M	Sell	35,689 -1,433	-4%	-$94.3K	2.09%	12
2019 Q1	$2.41M	Sell	37,122 -817	-2%	-$54.3K	2.11%	12
2018 Q4	$2.37M	Sell	37,939 -4,108	-10%	-$287K	2.31%	11
2018 Q3	$3.25M	Sell	42,047 -4,498	-10%	-$340K	2.34%	9
2018 Q2	$3.3M	Sell	46,545 -5,433	-10%	-$384K	2.28%	10
2018 Q1	$3.92M	Sell	51,978 -4,069	-7%	-$323K	2.3%	9
2017 Q4	$4.01M	Sell	56,047 -4,458	-7%	-$339K	2.4%	9
2017 Q3	$4.9M	Sell	60,505 -5,473	-8%	-$419K	2.81%	4
2017 Q2	$4.67M	Sell	65,978 -954	-1%	-$63.5K	2.79%	4
2017 Q1	$4.55M	Buy	66,932 +28,767	+75%	+$2.02M	2.7%	6
2016 Q4	$2.73M	Buy	38,165 +4,841	+15%	+$360K	1.76%	15
2016 Q3	$2.64M	Buy	33,324 +24,951	+298%	+$2.03M	1.75%	15
2016 Q2	$698K	Buy	+8,373	New	+$743K	0.46%	67

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sterneck Capital Management's GILD Position: Q3 2022 in Review

Sterneck Capital Management sold out of Gilead Sciences (GILD) in Q3 2022, closing a stake of 4,544 shares — an estimated $281K sold.

Sterneck Capital Management first reported a position in GILD in Q2 2016 and held it in 21 quarters. The position peaked at $4.9M in Q3 2017. 1,603 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

Sterneck Capital Management reported no remaining Gilead Sciences position as of Q3 2022 after selling out during the quarter.
Sterneck Capital Management sold 4,544 Gilead Sciences shares in Q3 2022, an estimated $281K.
Sterneck Capital Management first reported a position in Gilead Sciences in Q2 2016 and held it in 21 quarters.
Sterneck Capital Management's Gilead Sciences position peaked at $4.9M in Q3 2017.
1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on Sterneck Capital Management's 13F filing for Q3 2022, filed 13 Oct 2022.